18.09 USD
↗ 0.75 (4.33%)AT CLOSE (11:59 AM EDT)
Vor Biopharma Inc. Common Stock
VORNASDAQ • USD
18.17
↗ 0.08 (0.46%)
POST MARKET (AS OF 07:57 PM EDT)
Post Market
AS OF 07:57 PM EDT
18.17
↗ 0.08 (0.46%)
Market: CLOSED
Shares of Vor Biopharma Inc. Common Stock (VOR) are trading at $18.09. The stock presents a mixed profile: our models indicate a Buy for technical indicators, while underlying fundamentals flash a Sell. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (587.1%) and a bearish Death Cross on the long-term moving averages.
Technical & fundamental data as of Jul 17, 2026.
Open?$17.11
High?$18.24
Low?$16.67
Prev. Close?$17.34
Volume?999.0K
Avg. Volume?1.6M
VWAP?$17.85
Rel. Volume?0.64x
Bid / Ask
Bid?$17.90 × 400
Ask?$18.45 × 200
Spread?$0.55
Midpoint?$18.17
Valuation & Ratios
Market Cap?980.2M
Shares Out?54.2M
Float?29.2M
Float %?70.3%
P/E Ratio?N/A
P/B Ratio?-6.52
EPS?-$16.30
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
Themes
Employees
76
Market Cap
939.6M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2021-02-05
Address
500 BOYLSTON STREET
BOSTON, MA 02116
Phone: 617-655-6580
BOSTON, MA 02116
Phone: 617-655-6580
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?13
Piotroski F-Score?0/9Weak
Altman Z-Score?-4.18Distress
Confidence?56%Low
Short InterestSqueeze Risk
Short % of Float?26.53%Squeeze Risk
Short Interest?7.7M
Days to Cover?3.8
Free Float29.2M
Avg Daily Volume2.1M
Settlement Date2026-06-30
Financial Health
Current Ratio?31.15Strong
Quick Ratio?31.15Strong
Cash Ratio?10.57Strong
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?-6.52CHEAP▾
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-2.2CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?587.1%STRONG▾
Peers50
S&P97
ROA?-174.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-150651000
Enterprise Value?$810.3M
Fundamentals ratios updated end of day